Molecular mechanism of ischemic postconditioning in promoting diabetic ischemic brain injury repair via the microRNA-34a–BDNF–SIX3 signaling axisOA
Background:The underlying mechanisms for exacerbated brain injury and poor recovery observed in patients with diabetes and ischemic stroke(IS)remain undetermined.We explored the role of microRNA-34a(miR-34a)in diabetic IS(DMIS)and ischemic postconditioning(IPOC)''s neuroprotective effects in tree shrews.Methods:We established a tree shrew DMIS model and exposed it to interventions,including miR-34a inhibition(antagomir),IPOC,and miR-34a overexpression(agomir).Infarct size and pathology were assessed via staining.Cellular/molecular changes(astrocytes,neurons,brain-derived neurotrophic factor[BDNF],Sine oculis homeobox 3[SIX3],proliferation,apoptosis,axon formation)were analyzed using immunofluorescence,polymerase chain reaction(PCR),and Western blotting.In vitro,miR-34a''s targeting of BDNF/SIX3 was validated,with rescue experiments testing regulation via these factors.Results:Infarct size and neuronal damage were greater in the DMIS group than in the nondiabetic IS group.miR-34a inhibition or IPOC reduced infarcts,alleviated injury,improved cell survival,upregulated BDNF/SIX3,enhanced proliferation/axon formation,and reduced apoptosis.miR-34a overexpression reversed IPOC''s benefits.In vitro,miR-34a directly targeted BDNF/SIX3,suppressing their expression;exogenous BDNF/SIX3 rescued neurotoxicity and restored function.Conclusion:IPOC exerts partial neuroprotection through miR-34a downregulation,highlighting miR-34a as a potential therapeutic target.
Ling Zhao;Chunlan Zou;Junxian Li;Yang Yang;Yuanyuan Han;Tingyu Ke
Department of Endocrinology,The Second Affiliated Hospital of Kunming Medical University,Kunming,ChinaDepartment of Endocrinology,The Second Affiliated Hospital of Kunming Medical University,Kunming,ChinaDepartment of Endocrinology,The Second Affiliated Hospital of Kunming Medical University,Kunming,ChinaDepartment of Endocrinology,The Second Affiliated Hospital of Kunming Medical University,Kunming,ChinaInstitute of Medical Biology,Chinese Academy of Medical Science and Peking Union Medical College,Kunming,ChinaDepartment of Endocrinology,The Second Affiliated Hospital of Kunming Medical University,Kunming,China
医药卫生
BDNFdiabetes mellitusIPOCischemic strokemiR-34aSIX3
《Animal Models and Experimental Medicine》 2026 (6)
P.1126-1141,16
National Natural Science Foundation of China Project,Grant/Award Number:82201475Yunnan Province Xingdian Talents Support Program(Medical and Health Talents),Grant/Award Number:XDYC-YLWS-2024-0021Yunnan Provincial High-Level Scientific and Technological Talent and Innovation Team Selection Special—Young and Middle-Aged Academic and Technical Leaders Reserve Talent Project,Grant/Award Number:202405AC350061Yunnan Fundamental Research Kunming Medical University Joint Projects,Grant/Award Number:202401AY070001-0004Yunnan Health Training Project of High Level Talents,Grant/Award Number:L-2025011Kunming Medical University Second Affiliated Hospital Talent Training Project,Grant/Award Number:RCTDXS-202308。
评论